跳至主要内容
临床试验/JPRN-UMIN000028023
JPRN-UMIN000028023已完成未知

PrasugrEl moNotherapy after DrUg eLUting stent deployMent as a Management Of patients who are uNsuitable for lOng-term dual antiplatelet therapy - PENDULUM mono

Toho University Ohashi Medical Center0 个研究点目标入组 1,222 人开始时间: 2017年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
1,222

研究概览

简要总结

暂无简介。

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients are excluded from the study if any one of the following criteria is met: 1. Patients who requires dual antiplatelet therapy (DAPT) for at least 6 months from the viewpoint of a thrombotic risk 2. Bleeding patients (e.g., hemophilia, intracranial hemorrhage, gastrointestinal hemorrhage, urinary tract hemorrhage, hemoptysis, vitreous hemorrhage) 3. Patients who underwent PCI in coronary artery bypass graft as the target lesion(s) 4. Patients who are participating or plan to participate in a clinical study or clinical research requiring intervention for the choice of antiplatelet therapy before the end of follow-up in this study 5. Patients who are participating in the clinical study titled: Platelet rEactivity in patieNts with DrUg eLUting stent and balancing risk of bleeding and ischeMic event (PENDULUM registry, UMIN000020332)

研究者

相似试验

PrasugrEl moNotherapy after DrUg eLUting stent... | 临床试验